US 8486989
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61KA61K31/407A61K38/00
Quick answer
US patent 8486989 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/407, A61K38/00, A61K45/06, A61P